help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on June 19, 2008, doi:10.1165/rcmb.2008-0112OC

Am. J. Respir. Cell Mol. Biol., Volume 39, Number 6, December 2008, 683-688

A more recent version of this article appeared on December 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2008-0112OCv1
39/6/683    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Heyob, K. M
Right arrow Articles by Welty, S. E
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heyob, K. M
Right arrow Articles by Welty, S. E

Submitted on March 21, 2008
Revised on June 18, 2008

Glutathione Reductase Targeted to Type II Cells Does Not Protect Mice from Hyperoxic Lung Injury

Kathryn M Heyob1, Lynette K Rogers1, and Stephen E Welty1*

1 Department of Pediatrics, The Ohio State University, Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA

* To whom correspondence should be addressed. E-mail: stephen.welty{at}nationwidechildrens.org.

Exposure of the lung epithelium to reactive oxygen species without adequate antioxidant defenses leads to airway inflammation, and may contribute to lung injury. Glutathione peroxidase catalyzes the reduction of peroxides by oxidation of glutathione (GSH) to glutathione disulfide (GSSG), which can in turn be reduced by glutathione reductase (GR). Increased levels of GSSG have been shown to correlate negatively with outcome after oxidant exposure, and increased GR activity has been protective against hyperoxia in lung epithelial cells in vitro. We tested the hypothesis that increased GR expression targeted to type II alveolar epithelial cells would improve outcome in hyperoxia-induced lung injury. Human GR with a mitochondrial targeting sequence was targeted to mouse type II cells using the SPC promoter. Two transgenic lines were identified, with Line 2 having higher lung GR activities than Line 1. Both transgenic lines had lower lung GSSG levels and higher GSH/GSSG ratios than wild-type. Six week old wild-type and transgenic mice were exposed to >95% O2 or room air (RA) for 84h. After exposure, Line 2 mice had higher right lung/body weight ratios and lavage protein concentrations than wild-type, and both lines 1 and 2 had lower GSSG levels than wild-type. These findings suggest that GSSG accumulation in the lung may not play a significant role in the development of hyperoxic lung injury, or that compensatory responses to unregulated GR expression render animals more susceptible to hyperoxic lung injury.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2008 American Thoracic Society.
  ATS Best of the Web